Envoy Medical Inc. (COCH)
1.54
0.13 (9.22%)
At close: Jan 21, 2025, 3:58 PM
1.52
-1.30%
After-hours Jan 21, 2025, 03:59 PM EST
undefined% (undefined)
| Bid | 1.41 |
| Market Cap | 31.18M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.28 |
| PE Ratio (ttm) | -1.2 |
| Forward PE | n/a |
| Analyst | Strong Buy |
| Ask | 1.53 |
| Volume | 78,397 |
| Avg. Volume (20D) | 258,355 |
| Open | 1.43 |
| Previous Close | 1.41 |
| Day's Range | 1.29 - 1.56 |
| 52-Week Range | 1.08 - 11.46 |
| Beta | undefined |
About COCH
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota....
Industry Medical - Devices
Sector Healthcare
IPO Date Apr 29, 2021
Employees 34
Stock Exchange NASDAQ
Ticker Symbol COCH
Website https://www.envoymedical.com
Analyst Forecast
According to 3 analyst ratings, the average rating for COCH stock is "Strong Buy." The 12-month stock price forecast is $9, which is an increase of 484.42% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
Envoy Medical Inc. is scheduled to release its earnings on Apr 1, 2025,
before market opens.
Analysts project revenue of $77.50K, reflecting a -18.42% YoY shrinking and earnings per share of -0.31, making a -487.50% decrease YoY.
Analysts project revenue of $77.50K, reflecting a -18.42% YoY shrinking and earnings per share of -0.31, making a -487.50% decrease YoY.
5 months ago
+19.47%
Envoy Medical shares are trading higher. The compa...
Unlock content with
Pro Subscription
7 months ago
+1.75%
Envoy Medical shares are trading higher after Ascendiant Capital initiated coverage with a Buy rating and announced a price target of $8.50.
